Our 10 Top Turnaround Situations Under $5.00.
Can These Stocks Double in Value, and Still be 70% off Their Recent High?
Read More and Decide.
Point #1. We've been playing turnaround situations...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a biotechnology company...
Tsunami of Business Headed Pressure Bio’s (PBIO) Way?
We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond.
As the chart...
Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...
Initiating Coverage on Psycheceutical BioScience (BWVI).
"Imagine Applying a Psychedelic Topically, Receiving the Benefits Quicker Than Alternative Delivery Methods (Injection, Intravenously, Nasally or Orally) and...
Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the World?
We Think it is!
Webinar to discuss effectiveness.
The Company does not make CBD Oil, it makes any CBD Oil better.
Press release out today about their...
Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.
Cohen Psychedelic Research & Health Initiative
Cohen Foundation Awards $5 Million for MDMA Therapy Approval
Millions of Americans suffer from depression, anxiety, addiction, post-traumatic stress disorder...
Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...
Completion of Enrollment Remains on Track for Q1, 2024
"While we recently had fireworks, we could be looking at real fireworks in the coming year....
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...
Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests NeuroDirect™ Ketamine....
Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials
Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD.
Company raises $1.3M USD convertible note from Cantheon Capital for in-human trials...
Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.
Hepion Pharmaceuticals (HEPA) to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
https://youtu.be/CE7es4l1avM
EDISON, N.J., (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals,...
Latest article
Perpetua Resources (PPTA) Joins the Billion Dollar Club
Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources (PPTA) $13.60 to Watchlist. Antimony Heaven.2....
Blue Ocean Equities Report on Antimony.
Antimony Macro Note: Don’t expect Sb prices to pull back anytime soon!
ANTIMONY MACRO NOTE
On Gold Investment Conference
A simply fantastic report (best in world) though...
Gold Miners Printing Record Margins – Juniors Could 10x From Here | Video
Charles Haggar, Mathieu Boisvert and Michael Gentile
Will permitting reform in North America unlock trillions in hidden value? Gold and silver are soaring, but junior...
